Rein Therapeutics Inc.
RNTX
$0.92
-$0.03-2.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.16% | -75.01% | -77.07% | -73.89% | -38.32% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.63% | 40.28% | 9.11% | 3,420.00% | 3,512.00% |
| Total Current Assets | -34.55% | -68.32% | -72.31% | -71.49% | -34.73% |
|
|
|||||
| Total Current Assets | -34.55% | -68.32% | -72.31% | -71.49% | -34.73% |
| Net Property, Plant & Equipment | -- | -- | -- | -50.00% | -83.33% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -68.01% | -68.01% | -46.72% | -46.72% | -46.72% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 31.20% | 0.00% | 0.00% | 230.89% | -14.13% |
| Total Assets | -54.38% | -61.15% | -48.47% | -47.46% | -41.90% |
|
|
|||||
| Total Accounts Payable | 445.08% | 336.44% | 282.11% | 670.84% | -46.71% |
| Total Accrued Expenses | -51.22% | -55.34% | -66.56% | -61.97% | 122.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 7.32% | -19.67% | 56.16% | -28.24% | -41.43% |
| Total Other Current Liabilities | 7.32% | -19.67% | 56.16% | -28.24% | -41.43% |
| Total Current Liabilities | 128.16% | 7.50% | 1.50% | 55.84% | 31.88% |
|
|
|||||
| Total Current Liabilities | 128.16% | 7.50% | 1.50% | 55.84% | 31.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -40.18% | -48.27% | -46.72% | -48.52% | -46.72% |
| Total Liabilities | 89.66% | -7.16% | -16.35% | 12.97% | -1.39% |
|
|
|||||
| Common Stock & APIC | 3.30% | 3.45% | 2.73% | 1.70% | 6.28% |
| Retained Earnings | -14.07% | -14.19% | -18.97% | -19.42% | -20.73% |
| Treasury Stock & Other | -93.75% | -244.44% | -69.23% | 0.00% | 49.21% |
| Total Common Equity | -785.56% | -399.21% | -97.64% | -94.63% | -89.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | -3.39% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -3.39% |
|
|
|||||
| Total Common Equity | -785.56% | -399.21% | -97.64% | -94.63% | -89.11% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -3.39% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -76.76% | -68.90% | -51.50% | -52.47% | -45.39% |
|
|
|||||